Patents
Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621)
06/2008
06/04/2008CN101193855A Substituted aryl oximes
06/04/2008CN100391938C Preparation method of phenyl (S)-N-ethyl-N-methyl-3-[1-(dimethyamino)ethyl]-amidoformate (I) and tartrate thereof (II)
06/04/2008CN100391937C Acrylic acid semicrystal super branched polycarbamate oligo polymer and its preparation method
06/03/2008US7381813 A modified estrogen receptor alpha ligand binding domain containing an amino acid modification in region 1, at region 2, or atleast one amino acid modifiation in both of regions, and these domain interacts with a nonendogenous ligand
06/03/2008US7381745 Central nervous system disorders; psychological disorders
05/2008
05/29/2008WO2008062859A1 Process for production of phenylalanine derivatives having quinazolinedione skeletons and intermediates for the production
05/29/2008US20080125465 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
05/28/2008EP1925611A1 Optically active diamine derivative and process for producing the same
05/28/2008EP1924553A1 Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
05/27/2008US7378448 Diphenylether amide derivatives as opioid receptor antagonists
05/22/2008WO2008059953A1 Method for producing isocyanate
05/22/2008WO2008059299A1 CHIRAL CYCLIC ß-AMINO ACIDS AND THEIR DERIVATES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THE USE OF SUCH COMPOUNDS
05/22/2008WO2008059051A1 Synthesis of imide compounds
05/22/2008WO2008037503A3 Process for making aminoalkylphenyl carbamates and intermediates therefor
05/22/2008US20080119549 Phenyl esters of alkylcarbamic acids; analgesics
05/22/2008US20080119512 Carboxamide Derivatives as Therapeutic Agents
05/21/2008EP1923391A1 Substituted heterocyclic compounds, method for preparing same and pharmaceutical compositions containing them.
05/21/2008EP1831146B1 Hydroxycarbonylation of aryl and vinyl bromides
05/21/2008EP1395551B1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
05/21/2008EP1261586B1 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv, processes for their preparation, and their use
05/20/2008US7375093 Nuclear receptor-based inducible gene expression system
05/20/2008CA2395717C Fused imidazolium derivatives
05/20/2008CA2168692C Improved process for manufacturing methylene-bis(dibutyl-dithiocarbamate) with astm colour less than 2
05/15/2008US20080114179 Process and intermediates for the preparation of (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates for salts thereof
05/15/2008US20080113976 asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis; Azetidine-1-carboxylic acid {2-[({2-hydroxy-1-[(isopropyl-methyl-amino)-methyl]-pentylcarbamoyl}-methyl)-carbamoyl]-4-trifluoromethyl-phenyl}-amide
05/15/2008US20080112917 Sphingolipids' Polyalkylamines Conjugates
05/15/2008DE102005026500B4 Herstellung von N-Arylcarbamaten und N-Arylisocyanaten Preparation of N-aryl carbamates and N-aryl isocyanates
05/14/2008EP1921062A2 Amino acid derivatives as HIV aspartyl protease inhibitors
05/14/2008EP1919879A1 9-aminocarbonylsubstituted derivatives of glycylcyclines
05/14/2008EP1919859A2 Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use
05/14/2008EP1556338B1 A method of production of (-)-(s)-3- [1-(dimethylamino)ethyl] phenyl-n-ethyl-n-methylcarbamate
05/14/2008CN101180273A Methods of synthesizing 6-alkylaminoquinoline derivatives
05/14/2008CN100387581C Process to produce oxazolidinones
05/14/2008CN100387339C Use of tin derivatives as catalysts for transforming carbamates, carbamate compositions comprising said catalyst and method for transforming carbamates
05/13/2008US7371867 Non-racemic trifluoroleucine, and methods of making and using
05/13/2008US7371854 Method for the production of bicyclic aromatic amino acids and intermediate products thereof
05/13/2008CA2384027C Fungicides
05/08/2008WO2008052788A1 [f-18]-labeled l-glutamic acid, [f-18]-labeled l-glutamine, derivatives thereof and use thereof and processes for their preparation
05/08/2008CA2667395A1 [f-18]-labeled l-glutamic acid, [f-18]-labeled l-glutamine, their derivatives and their use and processes for their preparation
05/07/2008CN101175718A Processes for preparing biaryl ureas and analogs thereof
05/06/2008US7368585 Protected trihydroxyisoalkatrienyltriphenylphosphonium halides for proparing polyhydroxylactones; acid stable protecting groups include p-methoxybenzyl and tert-butyldimethylsilyl.
05/06/2008US7368572 Anticancer agents
05/06/2008CA2239694C Indane dimer compounds and their pharmaceutical use
04/2008
04/30/2008EP1506168B1 Gelling agents
04/30/2008EP1294747B1 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
04/29/2008US7365222 Polymerizable bicyclic cyclopropane derivatives and their use for the preparation of dental materials
04/29/2008US7365085 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption
04/24/2008WO2008046889A1 Enantiomer-enriched alpha-,omega amino alcohol derivatives, their production and use as insect- and mite-repelling agents
04/24/2008US20080096960 4-amino-3-(4-chlorophenyl)butanoic acid; prodrugs of baclofen and baclofen analogs; gamma aminobutanoic acid agonist; drug, nicotine, and narcotic abuse; antitussive, antiemetic agent; cough, nausea, vomiting; oral administration; sustained release dosage form
04/24/2008US20080096942 Beta-secretase inhibitors; use in treating Alzheimer's disease; for example, N-{(1S,2R)-1-[3-(cyclohexylmethyl)benzyl]-2-hydroxy-3-[(3-methoxybenzyl)amino]propyl}acetamide hydrochloride
04/24/2008US20080096875 Hepatitis C virus infection; thiourea-substituted dibenzofuran, fluorene, or carbazole compounds
04/24/2008US20080096869 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
04/24/2008US20080095704 A polyoxyethylene glycol having a molecular weight of < 3000 Da and 2-50 ethylene glycol units, an imageable moiety anda non-peptidic vector moiety provided that the vector does not have affinity for the Angiotensin II receptor; enhanced contrast; tomography (SPECT); PET sccans; MRIs
04/24/2008DE102006049763A1 Enantiomerenangereicherte alpha-, omega-Aminoalkohol-Derivate, ihre Herstellung und Verwendung als insekten- und milbenabwehrende Mittel Enantiomerically enriched alpha, omega-amino alcohol derivatives, their preparation and use as insect and mite repellents
04/24/2008CA2666878A1 Enantiomer-enriched alpha-,omega amino alcohol derivatives, their production and use as insect- and mite-repelling agents
04/23/2008EP1914224A1 Amorphous organic compound
04/23/2008CN100383116C Methoximinophenylacetic acid amides
04/23/2008CN100383110C Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases
04/22/2008US7361787 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent
04/22/2008US7361765 resides in the superior properties of the succinate salt of ((1R,3S)-3-isopropyl-3-{[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl}cyclopentyl)[(3S,4S)-3-methoxytetrahydro-2H-pyran-4-yl]amine
04/22/2008CA2180816C 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
04/17/2008WO2008045391A2 Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate
04/17/2008WO2008044731A1 N-phenyloxamidic acid derivative
04/17/2008WO2008043798A1 A PROCESS FOR THE PREPARATION OF β-AMINO ALDEHYDES AND DERIVATIVES THEREOF.
04/17/2008CA2665573A1 Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate
04/16/2008EP1911740A1 Potassium channel modulators
04/16/2008EP1910387A1 Compounds for preparing immunological adjuvant
04/16/2008EP1910279A2 Non-nucleoside anti-hepacivirus agents and uses thereof
04/16/2008EP1910272A1 Renin inhibitors
04/16/2008EP1909783A2 Illudin analogs useful as anticancer agents
04/16/2008EP1534334A4 Releasable polymeric conjugates based on aliphatic biodegradable linkers
04/16/2008EP1414787B1 New derivatives of substituted anilines with herbicidal activity
04/16/2008EP1238031B1 Curable coating compositions containing carbamate functional reactive additives
04/16/2008CN101163713A Compound having amino acid residue or peptide residue and process for producing the same
04/16/2008CN101163669A Acetylene derivatives
04/16/2008CN101161641A Tricyclic steroid hormone nuclear receptor modulators
04/16/2008CN100381418C Gelling agents
04/15/2008US7358264 Statine derivatives for the treatment of Alzheimer's disease
04/15/2008US7358073 Process for the preparation of aminoalcohol derivatives and their further conversion to (1R, 4S)-4(2-amino-6-chloro-5-formamido-4- pyrimidinyl)-amino-2-cyclopentenyl-1-methanol
04/15/2008CA2410303C Beta-amino acid nitrile derivatives
04/15/2008CA2328920C Novel derivatives of 3,3-diphenylpropylamines
04/15/2008CA2154424C 1-phenyl-3-dimethylaminopropane compounds having a pharmaceutical effect
04/10/2008US20080085930 Characterized by a powder X-ray diffraction pattern having one powder X-ray diffraction peak at about 10.0 degrees 2-theta; useful for treating and/or preventing central nervous system disorders such as epilepsy, stroke, muscle spasms, neuropathic pain, and migraine
04/10/2008US20080085891 Asthma and allergic inflammation modulators
04/09/2008EP1461320B1 Enantioselective transformation of alfa,beta-unsaturated ketones using chiral organic catalysts
04/09/2008CN101160286A Process for the preparation of ccr-2 antagonist
04/09/2008CN101157640A Acrylic polyurethane having star-structure six functional groups and synthesizing method thereof
04/08/2008US7354943 Statine derivatives for the treatment of Alzheimer's disease
04/03/2008WO2008039367A1 Synthesis of trans-tert-butyl-2-aminocyclopentylcarbamate
04/03/2008WO2008037503A2 Process for making aminoalkylphenyl carbamates and intermediates therefor
04/03/2008WO2008037433A1 Process for making aminoalkylphenyl carbamates and intermediates therefor
04/03/2008WO2007017728A3 Novel heterocyclic compounds
04/02/2008EP1201648B1 Carbamate derivatives and agricultural/horticultural bactericides
04/02/2008CN100378070C Process for preparing high purity iodo propargyl n-butyl carbamate
04/01/2008US7351852 T-butoxycarbonylaminoethylamine for the synthesis of PNA monomer units, amino acid derivatives, intermediates therof, and processes for productions of them
04/01/2008US7351849 Process for producing optically active β-amino acid derivatives
04/01/2008US7351740 Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use
04/01/2008US7351738 e.g., phenyl ((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)carbamate; inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide
04/01/2008CA2530543C Illudin analogs as anti-tumor agents
03/2008
03/26/2008EP1902714A1 Prodrugs of gaba analogs, compositions and uses thereof
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 157